Morgan Health Ventures

Our strategy leverages an extensive hospital system and health plan network of relationships to target attractive market segments, to identify and evaluate investment opportunities, and to support the growth of our portfolio companies. Current Areas of Focus:Administrative Automation Behavioral Health: HCIT & Services Data Security Digital Therapeutics Genomics: Applications & Analytics Patient Safety & Risk Monitoring Pharma Data & Analytics Platforms Social Determinants of Health Virtual Care Models Women’s Health: HCIT & Services

Rhia Ventures’ mission is to create a vibrant US market for sexual, reproductive, and maternal health that produces equitable outcomes for all. This multi-billion dollar market has tremendous potential for public health impact, but it has been built on flawed systems that perpetuate unjust outcomes for women of color, low-income women, and others directly affected by systemic inequities. Our work is to transform this market. We know that transformation happens when partners with long experience in reproductive health and justice come together with market-facing actors to create deep, meaningful impact. By connecting activists, public health professionals, scientists, entrepreneurs, corporates, and investors, together we will build a more just marketplace. Rhia is enabling this change through four complementary efforts: We make direct investments in early- and growth-stage companies that are driving innovation, access, and equity in reproductive and maternal health, through our wholly owned venture fund, RH Capital Corporation. We provide technical assistance and shared resources to these companies and others so that they can strengthen their work in health equity and spur change across the venture ecosystem. We work through our Corporate Engagement and Blossom programs to change social norms, practices, and people that influence this market. We produce a systems-change assessment of the market, identifying the key leverage points for addressing systemic racism and other inequities to inform Rhia’s programs and share with grant-makers, investors, and policy-makers seeking to “make this market work for justice,” to paraphrase Darren Walker of the Ford Foundation. Our Vision for Success Alongside our partners, our efforts will: Catalyze investment in innovation that improves equity, access, and outcomes in reproductive and maternal health care Transform systems in the reproductive and maternal health market, to redress systemic inequity and contributes to improving reproductive and maternal health outcomes for women of color, low-income women, and others directly affected by systemic inequities Amplify the perspectives and work of stakeholders of color Strengthen social norms, to support high-quality maternal and reproductive health care for all women and birthing people in the US

At Town Hall Ventures, we seek to partner with entrepreneurs who are as passionate as we are about changing our health care system. When we invest, we will make a substantial commitment of our time, network and resources to support entrepreneurs and their investors through the ups and downs of building successful companies. It’s why we choose to invest in fewer opportunities than most and only in the most impactful - focusing all of our energy working side-by-side with our partners to create and scale the breakthrough companies that will transform health care. Our Mission Using innovation to fix health inequities. Those fortunate enough to be born in the right zip code live longer and healthier lives than those in communities next door. Systemically, people who represent diverse racial, ethnic and gender identities, especially when combined with lower socioeconomic status, experience substantially worse health outcomes in the United States. These inequities in health - physical, mental and social determinants - result in individual, community and national struggles. When we provide great health care to the least fortunate, we are benefiting our entire societal fabric. We have an opportunity to shift investment away from nice-to-have ideas to proven solutions that improve care for populations that have long been underserved. Innovations aimed at improving care have been slow to come to areas that need it most, including: primary care, mental health, addiction, end-of-life care, kidney care, maternity and newborn health. The costs of ignoring these issues are carried by everyone. Enter the mission-driven entrepreneur. Over the past few years, innovative health care delivery approaches that serve Medicare populations have begun to emerge. Entrepreneurs have brought a new focus on reinvigorating primary care and pushing care into more comfortable settings. These models are just getting started, touching only 2% of the Medicare population today, but have tremendous potential to transform health for millions more. Thanks to an improved set of incentives, similar innovation is now coming to Medicaid. Entrepreneurs are beginning to focus on the needs of this population with the goal of dramatically improving health outcomes for patients and providing value to the hospitals, managed care plans, and State and Federal governments who care for them. Companies who create effective solutions to these challenges have the opportunity to improve the lives of 120 million Americans.

We build and invest in companies that positively impact human health with smart solutions, breakthrough science and technology. Our focus is on innovation in digital healthcare, connected medical devices, and life sciences We focus on therapeutic and preventive technology solutions addressing unmet needs in some of the most vulnerable segments of society: women, children and the elderly. Digital transformation will continue to shape our lives and has the potential to transform care. We aim to build and support Digital Health & Life Sciences companies working to make healthcare smarter, using data to improve care and outcomes, and reinventing the patient journey. Our vision for the future of healthcare guides our investment strategy. A data driven digital transformation will shape the future of healthcare. The traditional biopharma model will evolve into an integrated model, where prevention, precision cure, and care management will coexist in a highly personalized patient-centric solution. Our goal is to support the creation of life transforming care products and therapies. We believe the future of healthcare lies in supporting the next-generation of founders and teams who will lead us there. What do we look for?Innovation and groundbreaking opportunities in our sectors of focus: digital health, life sciences, tech-enabled care delivery, and connected devices Innovative treatments for Central Nervous System (CNS) disorders, in particular neurodevelopmental disorders, mental health and epilepsy Founders and teams with domain expertise who seek collaborative investment partners Investments that span development and commercial phases, with a focus on early stage opportunities (Pre-Seed to Series A). Our investment approachOur investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective. We invest primarily across Europe, North America and Israel, recognizing that healthcare technology innovation is occurring in many cities around the world. We have committed €300M for investments and company creation in digital health and life sciences. What do we commit to you?Active and involved healthcare investors who operate with integrity, approachability, and transparency A team of passionate healthcare and venture capital experts diverse in demographic and experience A track record of success and experience navigating the ups and downs of early-stage company building Access to a world-class advisory board to leverage C-level experience, expertise, and leadership in healthcare

SCOR Ventures is the venture investment arm of SCOR Reinsurance, responsible for both investing in and creating partnerships with startups across the insurtech landscape. Since 2017 we have built a global portfolio across three theses: (1) investing in tech-driven underwriting companies (MGAs, carriers) and distributors, (2) software solutions that benefit SCOR and/or our clients, and (3) companies that help people live healthier lives. Our investment scope includes both investments and commercial (re)insurance relationships with startups. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. What we’re looking for We invest across three thesis areas: Thesis 1: we invest and partner in the ‘Insurers of the Future’: tech-driven underwriting companies (MGAs, carriers) that offer multiple points of digital and business model differentiation across P&C and L&H. We provide direct access to SCOR expertise and our global network to help portfolio companies scale and/or access (re)insurance capacity. With a proven track record of supporting innovative underwriting propositions across multiple lines of business, we understand product development, program structuring, underwriting, pricing and distribution and thus have the capabilities to optimise partnerships between insurtechs and business partners. We predominantly invest at late Seed / Series A. We are class of business agnostic and have partnered with companies across a broad variety of personal and specialty lines. Thesis 2: we invest and partner in software solutions that benefit SCOR and/or our clients. We provide a broad understanding of the interests and pain points of insurers across the world, and the potential to connect companies with insurers through SCOR’s client services initiatives. We predominantly invest later stage vs. Thesis 1 (typically Series A-B) but have occasional appetite for Seed. We prioritise companies: developing data, tools, and methods for obtaining, understanding, pricing and transferring large portfolios of pre-aggregated risks, high-value individual risks such as energy facilities and construction mega-projects, and MGA/coverholder business delivering economically valuable additional services offering a visible outcome which can be used to boost client management or reduce risks. Focus areas include front-end (e.g., underwriting & pricing) policy administration, modelling, risk analytics, and claims developing platforms where insurance has not previously been embedded / distributed, but where SCOR Ventures sees substantial opportunities to close the global protection gap – e.g., marketplaces, “super apps”, b2b fintech, employee benefits working to solve climate and ESG challenges to support the net zero transition and cut emissions for SCOR and SCOR clients. Focus areas include ESG reporting, climate risk analysis and data, carbon offsetting as a solution, circular economy, diversity, equity, and inclusion (DEI) tech, and supply chain transparency. We also see several opportunities in the green insurance product space including solar production or maintenance guarantees, wind input parametric products, solar physical asset damage, cat-bond / ILS and insuring carbon credit projects. Thesis 3: We invest at the intersection of health and technology and partner with companies that help people live healthier lives, deliver in-force or claims outcome improvements, develop new business or add to SCOR’s Knowledge Center capabilities, and assist our clients to transform their offerings. We predominantly invest at late Seed / Series A and are interested in a broad range of B2B and B2B2C solutions across MedTech, wellness, wearables, data platforms, and software / AI platforms. How we operateIntegrated in the wider SCOR business: Direct access to the entirety of SCOR’s capabilities brings unique added value to our portfolio companies. SCOR’s core business has experts in nearly every country, line of business, and functional area, while SCOR Partners bring a broad range of client services, marketing and product development expertise. Mandate: focused on key markets in North America, EMEA and LATAM, with selective deployment in APAC and Africa. Stage and ownership: We invest Seed to Series B. We typically seek greater than 5% ownership at first investment, which may include a board seat (we have led or co-led half of our investments to date). Our investment is intended to make SCOR a meaningful contributor but leave founders room to manage their cap table. We look for a long-term investment and / or commercial relationship but do not seek a fast exit or to ultimately acquire portfolio companies. Partnership approach: we are active supporters of the companies we work with, assisting with technical input, recruitment, capital optimisation and more. The material growth of many insurtech MGAs and carriers has led to increasing demand for (re)insurance capacity; SCOR is a transparent, long-term partner. Insurtechs in SaaS and services segments, meanwhile, have benefited from SCOR’s long-standing client relationships, while SCOR benefits from bringing knowledge, links, and expertise regarding services with genuine value to our clients. We bring value to our portfolio companies by connecting them with other partner companies, as well as with founders and distribution leads in our network. Why partner with SCOR VenturesWe believe in fewer, deeper relationships over the long term. We are flexible and collaborative in our approach, tailoring a solution to your specific needs, in partnership with other insurers, reinsurers, and investors involved in your company as appropriate. We underwrite most major lines of business and geographies globally. We have a global network including insurance licenses but not a competing retail insurance arm. Insurers are our clients, so working with us does not limit your options to associate with insurers. In selected circumstances, we can offer access to Lloyd’s or SCOR’s insurance licenses in the U.S., Europe, Asia, Brazil, South Africa, and other markets. We look to move quickly with direct access to decision makers, whilst leveraging resources and expertise to ensure our partners can build relationships with the appropriate parts of our organization.